Clinical significance of cyclophosphamide-induced cardiotoxicity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Internal medicine

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.44.89PMID 15750266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclophosphamide-induced cardiomyopathy in a patient with seminoma and a history of mediastinal irradiation.

  2005cited by this paper
• Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging

  2003cited by this paper
• Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging.

  2003cited by this paper
• Apoptosis contributes to cyclophosphamide-induced cardiomyopathy

  2002cited by this paper
• Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m2) cyclophosphamide

  2001cited by this paper
• Fatal haemorrhagic myocarditis secondary to cyclophosphamide therapy.

  2000cited by this paper
• Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors

  2000cited by this paper
• Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer.

  2000cited by this paper
• In vivo prevention of cyclophosphamide-induced Ca2+ dependent damage of rat heart and liver mitochondria by cyclosporin A.

  1998cited by this paper
• Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor.

  1986cited by this paper
• Cardiotoxicity associated with high-dose cyclophosphamide therapy.

  1981cited by this paper
• The use of cyclophosphamide for clinical marrow transplantation.

  1972cited by this paper

• Suppression of glomerular damage, inflammation, apoptosis, and oxidative stress of acute kidney injury induced by cyclophosphamide toxicity using resveratrol in rat models.

  2024cites this paper
• The Role of curcumin extract in Ameliorating Cyclophosphamide-Induced Cardiotoxicity

  2023cites this paper
• Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future

  2023cites this paper
• New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies

  2022cites this paper
• Ivabradine as an Adjuvant Agent for Severe Heart Failure Occurring in the Early Phase after Allogeneic Hematopoietic Cell Transplantation

  2022cites this paper
• Low dose gamma irradiation attenuates cyclophosphamide-induced cardiotoxicity in rats: role of NF-κB signaling pathway

  2021cites this paper
• The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity

  2020cites this paper
• Role of alpha lipoic acid on cyclophosphamide induced cardiotoxicity in adult male albino rat: histological study

  2019cites this paper
• The possible protective effect of Zingiber officinale extract on cyclophosphamide-induced cardiotoxicity in adult male albino rats

  2019cites this paper
• Monitoring the side effects with DSC caused by cyclophosphamide treatment

  2019cites this paper
• Molecular mechanism involved in cyclophosphamide‐induced cardiotoxicity: Old drug with a new vision

  2019cites this paper
• Low-Dose Radiation Prevents Chemotherapy-Induced Cardiotoxicity

  2019cites this paper
• Low-Dose Radiation Prevents Chemotherapy-Induced Cardiotoxicity

  2019cites this paper
• Anti-cancer agents and endothelium

  2018cites this paper
• Cardiovascular Risk in Cancer Survivors

  2018cites this paper
• Endothelial dysfunction in patients with granulomatosis with polyangiitis: a case–control study

  2018cites this paper
• Chemotherapeutic Agents Associated With risk of Cardiotoxicity 5-Fluorouracil and Capecitabine

  2018cites this paper
• Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography

  2018cites this paper
• New possibilities of application of DSC as a new clinical diagnostic method

  2018cites this paper
• Examination of the left ventricle damage in cyclophosphamide monotherapy with DSC in animal models

  2017cites this paper
• Mangiferin protects rat myocardial tissue against cyclophosphamide induced cardiotoxicity

  2017cites this paper
• Cyclophosphamide-induced changes in plasma and red blood cells detected by differential scanning calorimetry (DSC) in guinea pigs

  2017cites this paper
• Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights

  2017cites this paper
• Cardiovascular Toxicity and Monitoring Methods in Oncologic Patients

  2015cites this paper
• Cardiovascular disease in adult survivors of childhood cancer.

  2015cites this paper
• Cardiotoxicity induced by cyclophosphamide in rats : Protective effect of curcumin

  2015influential citation
• State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review.

  2013cites this paper
• 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology.

  2012cites this paper
• Cardiovascular Complications of Cancer Therapeutics

  2011cites this paper
• 7 – Principles and Guidelines of Immunotherapy in Neuromuscular Disorders

  2011cites this paper
• Increased arterial stiffness in children treated with anthracyclines for malignant disease.

  2011cites this paper
• Drug-related cardiotoxicity for the treatment of haematological malignancies in elderly.

  2010cites this paper
• Cardiovascular side-effects of modern cancer therapy.

  2010cites this paper
• не-антраЦиКлиновая КардиотоК сичность м.г . матяш, т.л. Кравчук, в.в. высоцкая, в.и. чернов, в.е. г ольдберг

  2009cites this paper
• Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione.

  2009influential citation
• Drug-related cardiac pathology

  2009cites this paper
• Cardiovascular toxicity associated with cancer treatment.

  2008cites this paper
• OBRAVNAVA HEMATOLOŠKIH BOLNIKOV, ZDRAVLJENIH S KARDIOTOKSIČNIMI ZDRAVILI MANAGEMENT OF HAEMATOLOGICAL PATIENTS TREATED WITH CARDIOTOXIC DRUGS

  2008cites this paper
• Manifestaciones cardiovasculares en el lupus eritematoso generalizado

  2008cites this paper
• Cardiac assessment of patients for haematopoietic stem cell transplantation.

  2007cites this paper
• Diastolic function of the heart in mixed connective tissue disease

  2006cites this paper
• The cardiotoxicity of chemotherapy: New prospects for an old problem

  2006cites this paper
• Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation

  2005cites this paper